Home/Investors/Y Combinator

Y Combinator

Biotech Investor · 8 portfolio companies

Portfolio

8

Focus Areas

11

Top Stage

Pre-clinical

Investment Focus

Oncology Immunology Infectious Disease Endocrine Disorders Type 1 Diabetes Major Depressive Disorder Anxiety Disorders Opioid Use Disorder Psychiatric Diseases Psychiatry Neurology

Portfolio Companies

Company	Stage	Valuation	Focus
General Proximity	Pre-clinical	—	Oncology, Immunology
Zeon Systems	—	—	—
Uh-Oh Labs	Commercial	—	Infectious Disease
Isabi	—	—	Oncology
Menten AI	Pre-clinical	—	—
Encellin	Phase 1	—	Endocrine Disorders, Type 1 Diabetes
Gilgamesh Pharmaceuticals	Phase 2	—	Major Depressive Disorder, Anxiety Disorders
Actipulse Neuroscience	Phase 3	—	Psychiatry, Neurology

Frequent Co-Investors

Khosla Ventures1 shared Two Sigma Ventures1 shared Healthspan Capital1 shared Wilson Sonsini1 shared Age11 shared Felicis Ventures1 shared Olive Capital1 shared Modi Ventures1 shared